Adaptive immunity involves antigen‐presenting cells (APC) like DCs, which capture antigens on cancer cell surfaces and present them to CD8+ T cells and CD4+ T cells through major histocompatibility complex (MHC)‐I class and MHC‐II class pathways [90]. Here, CD8A is linked to cancer.